CPhI Biopharma News

Oct 17, 2017
By BioPharm International Editors
DSM Sinochem Pharmaceuticals has filed a lawsuit against CSPC Pharmaceutical Group, Inner Mongolia Changsheng Pharmaceutical Company, and CSPC Zhangnuo Pharmaceutical (Shijiazhuang) for infringement of its amoxicillin patent.
Oct 17, 2017
By BioPharm International Editors
Almac Group’s Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is available in the United States.
Oct 04, 2017
By BioPharm International Editors
Aptar Pharma will be a main exhibitor at CPhI Worldwide 2017 and will deliver three briefings on company drug-delivery developments.
Aug 01, 2017
By BioPharm International Editors
The CPhI expert panel predicted in past annual reports the advancement of QbD, continuous processing, and a rise in FDA warning letters.
Jul 11, 2017
By BioPharm International Editors
The 2017 CPhI Pharma Awards program features 20 categories covering achievements in the pharma industry.
May 09, 2017
By BioPharm International Editors
CPhI Worldwide announced new additions to its 2017 advisory board.
May 08, 2017
Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.
Apr 24, 2017
By BioPharm International Editors
Companies believe that biologics and biosimilars would experience the fastest growth over the next year; there is also interest on increasing market penetration of generic drugs.
Apr 13, 2017
Pharmaceutical Technology spoke with CPhI North America presenter Jonathan Helfgott to discuss navigating GDUFA and helpful tips for submitting successful ANDAs.
Apr 13, 2017
At CPhI North America 2017, the US Pharmacopeial Convention will be discussing its upcoming revision and modernization of the standards for elemental and organic impurities.
native1_300x100
lorem ipsum